Clinical trial
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast…
NCT00003352 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00003352 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer |
| Official title | A Phase II Study in Patients With Metastatic or Locally Advanced Breast Cancer to Evaluate the Worth of the Combination of Adriamycin (Doxorubicin), Taxotere (Docetaxel), and Cyclophosphamide (ATC) |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, Taxotere, Adriamycin |
| Enrollment | 89 |
| Start date | Jun 1, 1998 |
| Primary completion | Sep 1, 2000 |
| Completion | Dec 1, 2002 |
| First posted | Jun 27, 2003 |
| Last update posted | Dec 11, 2012 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: